RAND Corporation, Santa Monica, California.
Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
JAMA Netw Open. 2022 Jul 1;5(7):e2221316. doi: 10.1001/jamanetworkopen.2022.21316.
The US health care system is experiencing a sharp increase in opioid-related adverse events and spending, and opioid overprescription may be a key factor in this crisis. Ambient opioid exposure within households is one of the known major dangers of overprescription.
To quantify the association between the postsurgical initiation of prescription opioid use in opioid-naive patients and the subsequent prescription opioid misuse and chronic opioid use among opioid-naive family members.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted using administrative data from the database of a US commercial insurance provider with more than 35 million covered individuals. Participants included pairs of patients who underwent surgery from January 1, 2008, to December 31, 2016, and their family members within the same household. Data were analyzed from January 1 to November 30, 2018.
Duration of opioid exposure and refills of opioid prescriptions received by patients after surgery.
Risk of opioid misuse and chronic opioid use in family members were calculated using inverse probability weighted Cox proportional hazards regression models.
The final cohort included 843 531 pairs of patients and family members. Most pairs included female patients (445 456 [52.8%]) and male family members (442 992 [52.5%]), and a plurality of pairs included patients in the 45 to 54 years age group (249 369 [29.6%]) and family members in the 15 to 24 years age group (313 707 [37.2%]). A total of 3894 opioid misuse events (0.5%) and 7485 chronic opioid use events (0.9%) occurred in family members. In adjusted models, each additional opioid prescription refill for the patient was associated with a 19.2% (95% CI, 14.5%-24.0%) increase in hazard of opioid misuse in family members. The risk of opioid misuse appeared to increase only in households in which the patient obtained refills. Family members in households with any refill had a 32.9% (95% CI, 22.7%-43.8%) increased adjusted hazard of opioid misuse. When patients became chronic opioid users, the hazard ratio for opioid misuse among family members was 2.52 (95% CI, 1.68-3.80), and similar patterns were found for chronic opioid use.
This cohort study found that opioid exposure was a household risk. Family members of a patient who received opioid prescription refills after surgery had an increased risk of opioid misuse and chronic opioid use.
美国医疗保健系统正经历阿片类药物相关不良事件和支出的急剧增加,阿片类药物的过度处方可能是这场危机的关键因素。家庭内的环境阿片类药物暴露是过度处方的已知主要危险之一。
量化接受阿片类药物的术后初始处方的阿片类药物患者与随后的阿片类药物滥用和家庭中阿片类药物患者的慢性阿片类药物使用之间的关联。
设计、环境和参与者:这项队列研究使用了来自美国一家拥有超过 3500 万参保人员的商业保险提供商数据库的管理数据进行。参与者包括 2008 年 1 月 1 日至 2016 年 12 月 31 日期间接受手术的患者及其同一家庭中的家庭成员。数据分析于 2018 年 1 月 1 日至 11 月 30 日进行。
患者术后接受的阿片类药物暴露时间和阿片类药物处方的补充。
使用逆概率加权 Cox 比例风险回归模型计算家庭成员中阿片类药物滥用和慢性阿片类药物使用的风险。
最终队列包括 843531 对患者和家庭成员。大多数对包括女性患者(445456[52.8%])和男性家庭成员(442992[52.5%]),大多数对包括年龄在 45 至 54 岁的患者(249369[29.6%])和年龄在 15 至 24 岁的家庭成员(313707[37.2%])。家庭成员中共有 3894 例阿片类药物滥用事件(0.5%)和 7485 例慢性阿片类药物使用事件(0.9%)。在调整后的模型中,患者每增加一次阿片类药物处方补充,家庭成员发生阿片类药物滥用的风险就会增加 19.2%(95%CI,14.5%-24.0%)。阿片类药物滥用的风险似乎仅在患者获得补充的家庭中增加。在有任何补充的家庭中,家庭成员发生阿片类药物滥用的风险增加了 32.9%(95%CI,22.7%-43.8%)。当患者成为慢性阿片类药物使用者时,家庭成员发生阿片类药物滥用的风险比为 2.52(95%CI,1.68-3.80),慢性阿片类药物使用也存在类似模式。
这项队列研究发现,阿片类药物暴露是家庭风险。接受阿片类药物处方补充的患者的家庭成员发生阿片类药物滥用和慢性阿片类药物使用的风险增加。